Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Orthopedics | 6 | 2020 | 124 | 1.400 |
Why?
|
Osteochondrodysplasias | 4 | 2021 | 11 | 1.360 |
Why?
|
Burnout, Professional | 3 | 2020 | 93 | 1.320 |
Why?
|
Practice Guidelines as Topic | 11 | 2019 | 1030 | 0.990 |
Why?
|
Colonic Neoplasms | 15 | 2018 | 554 | 0.920 |
Why?
|
Evidence-Based Medicine | 7 | 2013 | 429 | 0.830 |
Why?
|
Societies, Medical | 5 | 2020 | 572 | 0.800 |
Why?
|
Arthritis, Juvenile | 1 | 2021 | 32 | 0.800 |
Why?
|
Workplace | 1 | 2020 | 27 | 0.750 |
Why?
|
Orthopedic Surgeons | 1 | 2020 | 17 | 0.750 |
Why?
|
Pediatrics | 4 | 2019 | 344 | 0.730 |
Why?
|
Osteoarthritis, Knee | 4 | 2023 | 63 | 0.700 |
Why?
|
Occupational Health | 1 | 2019 | 32 | 0.680 |
Why?
|
Organizational Policy | 1 | 2019 | 55 | 0.670 |
Why?
|
Self Report | 1 | 2020 | 287 | 0.670 |
Why?
|
Humans | 117 | 2023 | 86281 | 0.660 |
Why?
|
Colorectal Neoplasms | 8 | 2018 | 924 | 0.650 |
Why?
|
Empathy | 1 | 2020 | 147 | 0.650 |
Why?
|
Spectrum Analysis | 10 | 2015 | 118 | 0.650 |
Why?
|
Hip Dislocation, Congenital | 5 | 2015 | 13 | 0.620 |
Why?
|
Achondroplasia | 4 | 2018 | 8 | 0.610 |
Why?
|
Editorial Policies | 1 | 2017 | 32 | 0.600 |
Why?
|
Physicians | 3 | 2020 | 672 | 0.590 |
Why?
|
Musculoskeletal Abnormalities | 3 | 2019 | 9 | 0.570 |
Why?
|
Clavicle | 2 | 2013 | 11 | 0.560 |
Why?
|
Rectum | 7 | 2018 | 146 | 0.540 |
Why?
|
Adenoma | 9 | 2015 | 234 | 0.540 |
Why?
|
Periodicals as Topic | 1 | 2017 | 167 | 0.520 |
Why?
|
Knee Prosthesis | 2 | 2023 | 33 | 0.510 |
Why?
|
Videotape Recording | 1 | 2014 | 47 | 0.480 |
Why?
|
Colonoscopy | 5 | 2022 | 260 | 0.480 |
Why?
|
Community Health Workers | 1 | 2014 | 26 | 0.470 |
Why?
|
North America | 3 | 2020 | 179 | 0.460 |
Why?
|
Gastrointestinal Diseases | 2 | 2011 | 145 | 0.430 |
Why?
|
Esophagus | 2 | 2013 | 102 | 0.430 |
Why?
|
Health Promotion | 1 | 2014 | 160 | 0.420 |
Why?
|
Cerebral Palsy | 4 | 2000 | 90 | 0.420 |
Why?
|
Exostoses, Multiple Hereditary | 1 | 2011 | 2 | 0.420 |
Why?
|
Exostoses | 1 | 2011 | 3 | 0.420 |
Why?
|
Baroreflex | 1 | 2011 | 17 | 0.420 |
Why?
|
Fractures, Bone | 1 | 2013 | 131 | 0.410 |
Why?
|
Blood Vessels | 1 | 2011 | 94 | 0.410 |
Why?
|
Health Services | 1 | 2011 | 55 | 0.400 |
Why?
|
Colon | 7 | 2012 | 495 | 0.400 |
Why?
|
Intestinal Mucosa | 10 | 2015 | 788 | 0.400 |
Why?
|
Dental Care for Children | 1 | 2010 | 1 | 0.390 |
Why?
|
Femur | 3 | 2021 | 116 | 0.390 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2014 | 427 | 0.380 |
Why?
|
Quality of Health Care | 2 | 2020 | 380 | 0.380 |
Why?
|
Abnormalities, Multiple | 4 | 2003 | 232 | 0.380 |
Why?
|
Pancreatic Neoplasms | 5 | 2015 | 645 | 0.370 |
Why?
|
Male | 53 | 2020 | 40860 | 0.360 |
Why?
|
Checklist | 2 | 2021 | 57 | 0.360 |
Why?
|
Child | 27 | 2021 | 6913 | 0.350 |
Why?
|
Hospitals | 1 | 2011 | 290 | 0.340 |
Why?
|
Esophageal Spasm, Diffuse | 1 | 2008 | 2 | 0.340 |
Why?
|
Barium Sulfate | 1 | 2008 | 43 | 0.330 |
Why?
|
Exercise | 1 | 2011 | 315 | 0.320 |
Why?
|
Female | 48 | 2022 | 44405 | 0.320 |
Why?
|
Bone Diseases, Developmental | 4 | 1996 | 11 | 0.320 |
Why?
|
Orthopedic Procedures | 4 | 2015 | 128 | 0.310 |
Why?
|
Spinal Fusion | 3 | 2020 | 85 | 0.310 |
Why?
|
Down Syndrome | 4 | 1993 | 53 | 0.300 |
Why?
|
Disease Management | 4 | 2019 | 327 | 0.300 |
Why?
|
Radiography | 17 | 2011 | 812 | 0.300 |
Why?
|
Fracture Fixation | 3 | 2012 | 31 | 0.300 |
Why?
|
Surveys and Questionnaires | 3 | 2020 | 2495 | 0.280 |
Why?
|
Humeral Fractures | 2 | 2019 | 16 | 0.280 |
Why?
|
Foramen Magnum | 2 | 2016 | 5 | 0.280 |
Why?
|
Growth Disorders | 2 | 2003 | 63 | 0.270 |
Why?
|
Infant | 15 | 2021 | 3036 | 0.260 |
Why?
|
Delivery of Health Care | 2 | 2020 | 423 | 0.260 |
Why?
|
Biomarkers, Tumor | 7 | 2018 | 1461 | 0.250 |
Why?
|
Body Height | 2 | 2018 | 99 | 0.250 |
Why?
|
Hip Joint | 4 | 1994 | 55 | 0.250 |
Why?
|
Precancerous Conditions | 4 | 2015 | 196 | 0.250 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2004 | 70 | 0.250 |
Why?
|
Synovial Membrane | 2 | 2018 | 28 | 0.250 |
Why?
|
Knee Joint | 3 | 2023 | 168 | 0.240 |
Why?
|
Range of Motion, Articular | 3 | 2003 | 154 | 0.240 |
Why?
|
Cholangiocarcinoma | 1 | 2004 | 66 | 0.240 |
Why?
|
Bile Duct Neoplasms | 1 | 2004 | 79 | 0.240 |
Why?
|
Arthroscopy | 7 | 2023 | 94 | 0.240 |
Why?
|
Child, Preschool | 12 | 2021 | 3608 | 0.230 |
Why?
|
Duodenum | 3 | 2015 | 99 | 0.230 |
Why?
|
Mass Screening | 2 | 2008 | 615 | 0.220 |
Why?
|
Early Detection of Cancer | 5 | 2015 | 387 | 0.220 |
Why?
|
Hypertension | 1 | 2011 | 1139 | 0.220 |
Why?
|
Colitis, Microscopic | 1 | 2022 | 5 | 0.220 |
Why?
|
Joint Instability | 3 | 2003 | 81 | 0.220 |
Why?
|
Prosthesis-Related Infections | 2 | 2013 | 58 | 0.220 |
Why?
|
Osteochondritis Dissecans | 2 | 2012 | 5 | 0.210 |
Why?
|
Adult | 23 | 2020 | 25577 | 0.210 |
Why?
|
Middle Aged | 25 | 2020 | 24957 | 0.210 |
Why?
|
Adolescent | 17 | 2021 | 8968 | 0.210 |
Why?
|
Colonic Polyps | 4 | 2011 | 126 | 0.210 |
Why?
|
Sigmoidoscopy | 3 | 2010 | 36 | 0.210 |
Why?
|
Scattering, Radiation | 6 | 2013 | 114 | 0.200 |
Why?
|
Toes | 1 | 2021 | 14 | 0.200 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2023 | 111 | 0.200 |
Why?
|
Aged | 17 | 2020 | 18353 | 0.200 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 2 | 2018 | 21 | 0.200 |
Why?
|
Fractures, Compression | 2 | 2011 | 17 | 0.200 |
Why?
|
Tomography, X-Ray Computed | 3 | 2008 | 2594 | 0.200 |
Why?
|
Ankle | 2 | 2000 | 20 | 0.200 |
Why?
|
Adenocarcinoma | 3 | 2015 | 1160 | 0.200 |
Why?
|
Polyethylene Glycols | 2 | 2018 | 363 | 0.200 |
Why?
|
Sensitivity and Specificity | 9 | 2015 | 1987 | 0.190 |
Why?
|
Spine | 2 | 2020 | 102 | 0.190 |
Why?
|
Achilles Tendon | 2 | 2010 | 15 | 0.190 |
Why?
|
Materials Testing | 2 | 2018 | 91 | 0.190 |
Why?
|
Functional Neuroimaging | 1 | 2020 | 32 | 0.190 |
Why?
|
Spinal Fractures | 2 | 2011 | 75 | 0.190 |
Why?
|
Radius Fractures | 2 | 2011 | 30 | 0.190 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2022 | 241 | 0.190 |
Why?
|
Neuromuscular Agents | 1 | 2000 | 20 | 0.190 |
Why?
|
Botulinum Toxins, Type A | 1 | 2000 | 42 | 0.180 |
Why?
|
Gait | 1 | 2000 | 80 | 0.180 |
Why?
|
Patient Preference | 1 | 2020 | 104 | 0.180 |
Why?
|
Infant, Newborn | 11 | 2021 | 2369 | 0.180 |
Why?
|
Aspirin | 2 | 2022 | 156 | 0.170 |
Why?
|
Collagen Type II | 1 | 2019 | 14 | 0.170 |
Why?
|
Anticarcinogenic Agents | 2 | 2018 | 70 | 0.170 |
Why?
|
Diagnosis, Differential | 5 | 2011 | 1562 | 0.170 |
Why?
|
Foot Deformities, Congenital | 2 | 2000 | 10 | 0.170 |
Why?
|
Musculoskeletal System | 1 | 1998 | 14 | 0.170 |
Why?
|
Job Satisfaction | 1 | 2019 | 73 | 0.170 |
Why?
|
Sutures | 1 | 2018 | 51 | 0.170 |
Why?
|
Aberrant Crypt Foci | 1 | 2018 | 7 | 0.160 |
Why?
|
Chondroitinsulfatases | 1 | 2018 | 1 | 0.160 |
Why?
|
Mucopolysaccharidosis IV | 1 | 2018 | 2 | 0.160 |
Why?
|
Laxatives | 1 | 2018 | 13 | 0.160 |
Why?
|
Young Adult | 5 | 2020 | 5961 | 0.160 |
Why?
|
Health Status | 2 | 1998 | 360 | 0.160 |
Why?
|
Inflammation Mediators | 1 | 2018 | 154 | 0.160 |
Why?
|
Desensitization, Immunologic | 1 | 2018 | 36 | 0.160 |
Why?
|
Prenatal Diagnosis | 1 | 2018 | 104 | 0.160 |
Why?
|
Tibia | 3 | 1994 | 82 | 0.160 |
Why?
|
Sleep Apnea Syndromes | 2 | 2016 | 102 | 0.160 |
Why?
|
Fiber Optic Technology | 2 | 2015 | 35 | 0.160 |
Why?
|
Rituximab | 1 | 2018 | 116 | 0.150 |
Why?
|
Methotrexate | 1 | 2018 | 249 | 0.150 |
Why?
|
Education, Medical | 1 | 2020 | 231 | 0.150 |
Why?
|
Biopsy | 4 | 2015 | 1160 | 0.150 |
Why?
|
Patient Safety | 1 | 2019 | 212 | 0.140 |
Why?
|
Nerve Net | 1 | 2020 | 366 | 0.140 |
Why?
|
United States | 6 | 2021 | 6637 | 0.140 |
Why?
|
Duodenoscopy | 1 | 2015 | 8 | 0.140 |
Why?
|
Platelet-Derived Growth Factor | 5 | 1996 | 67 | 0.140 |
Why?
|
Treatment Outcome | 5 | 2023 | 7949 | 0.140 |
Why?
|
Risk Factors | 10 | 2022 | 5397 | 0.140 |
Why?
|
Perioperative Care | 1 | 2017 | 161 | 0.130 |
Why?
|
Tomography, Optical Coherence | 2 | 2014 | 130 | 0.130 |
Why?
|
Pregnancy Complications | 1 | 2018 | 336 | 0.130 |
Why?
|
Mutation | 3 | 2018 | 3952 | 0.130 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1996 | 302 | 0.130 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 368 | 0.130 |
Why?
|
ErbB Receptors | 1 | 2018 | 485 | 0.130 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 610 | 0.130 |
Why?
|
Fatty Acid Synthases | 1 | 2014 | 8 | 0.130 |
Why?
|
Decision Making | 1 | 2020 | 641 | 0.130 |
Why?
|
Escherichia | 1 | 1994 | 1 | 0.120 |
Why?
|
Braces | 3 | 2013 | 13 | 0.120 |
Why?
|
Foreign-Body Reaction | 1 | 1994 | 11 | 0.120 |
Why?
|
Wood | 1 | 1994 | 19 | 0.120 |
Why?
|
Cervical Vertebrae | 2 | 1993 | 79 | 0.120 |
Why?
|
Enterobacteriaceae Infections | 1 | 1994 | 22 | 0.120 |
Why?
|
Aged, 80 and over | 7 | 2018 | 6481 | 0.120 |
Why?
|
Osteomyelitis | 1 | 1994 | 54 | 0.120 |
Why?
|
Rats | 8 | 2018 | 3984 | 0.120 |
Why?
|
Inservice Training | 1 | 2014 | 38 | 0.120 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2014 | 69 | 0.120 |
Why?
|
Wounds, Penetrating | 1 | 1994 | 46 | 0.120 |
Why?
|
Tendon Injuries | 2 | 2010 | 37 | 0.120 |
Why?
|
American Dental Association | 1 | 2013 | 9 | 0.120 |
Why?
|
Dental Care | 1 | 2013 | 11 | 0.120 |
Why?
|
Ultrasonography, Prenatal | 1 | 1994 | 152 | 0.110 |
Why?
|
Dental Implants | 1 | 2013 | 10 | 0.110 |
Why?
|
Point-of-Care Systems | 2 | 2015 | 141 | 0.110 |
Why?
|
Oral Surgical Procedures | 1 | 2013 | 19 | 0.110 |
Why?
|
Forearm | 2 | 2011 | 32 | 0.110 |
Why?
|
Sports | 1 | 1993 | 39 | 0.110 |
Why?
|
Light | 6 | 2013 | 289 | 0.110 |
Why?
|
Barrett Esophagus | 1 | 2013 | 93 | 0.110 |
Why?
|
Administrative Personnel | 1 | 2012 | 8 | 0.110 |
Why?
|
Surgeons | 1 | 2016 | 236 | 0.110 |
Why?
|
Leg | 2 | 2011 | 136 | 0.110 |
Why?
|
Conflict of Interest | 1 | 2012 | 67 | 0.110 |
Why?
|
Lower Body Negative Pressure | 1 | 2011 | 3 | 0.110 |
Why?
|
Cost Allocation | 1 | 2011 | 5 | 0.110 |
Why?
|
Hyperemia | 1 | 2011 | 19 | 0.110 |
Why?
|
Osteoporosis | 2 | 2011 | 121 | 0.110 |
Why?
|
Bicycling | 1 | 2011 | 12 | 0.100 |
Why?
|
Nails, Malformed | 1 | 2011 | 3 | 0.100 |
Why?
|
Prospective Studies | 6 | 2021 | 4194 | 0.100 |
Why?
|
Nails | 1 | 2011 | 7 | 0.100 |
Why?
|
Pressoreceptors | 1 | 2011 | 22 | 0.100 |
Why?
|
Fractures, Spontaneous | 1 | 2011 | 11 | 0.100 |
Why?
|
Hospital Bed Capacity | 1 | 2011 | 20 | 0.100 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2011 | 13 | 0.100 |
Why?
|
Vascular Resistance | 1 | 2011 | 99 | 0.100 |
Why?
|
Vascular Stiffness | 1 | 2011 | 26 | 0.100 |
Why?
|
Carcinogenesis | 1 | 2013 | 194 | 0.100 |
Why?
|
Muscular Diseases | 1 | 2012 | 63 | 0.100 |
Why?
|
Rotator Cuff | 1 | 2012 | 44 | 0.100 |
Why?
|
Shoulder Joint | 2 | 2010 | 90 | 0.100 |
Why?
|
Osteochondroma | 1 | 1991 | 7 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2015 | 1200 | 0.100 |
Why?
|
Scoliosis | 2 | 1994 | 31 | 0.100 |
Why?
|
Uncompensated Care | 1 | 2010 | 2 | 0.100 |
Why?
|
Dental Clinics | 1 | 2010 | 3 | 0.100 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 220 | 0.100 |
Why?
|
Oxygen Consumption | 1 | 2011 | 239 | 0.100 |
Why?
|
Esophageal Neoplasms | 1 | 2013 | 320 | 0.100 |
Why?
|
Israel | 1 | 2010 | 55 | 0.100 |
Why?
|
Bone Neoplasms | 3 | 1992 | 322 | 0.100 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 468 | 0.100 |
Why?
|
Carotid Arteries | 1 | 2011 | 127 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 1991 | 102 | 0.100 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 69 | 0.100 |
Why?
|
Blood Proteins | 1 | 2011 | 144 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2009 | 152 | 0.090 |
Why?
|
Health Care Costs | 1 | 2012 | 237 | 0.090 |
Why?
|
Osteoporotic Fractures | 1 | 2011 | 38 | 0.090 |
Why?
|
Physical Examination | 4 | 2010 | 149 | 0.090 |
Why?
|
Diagnostic Equipment | 1 | 2009 | 3 | 0.090 |
Why?
|
Microvessels | 1 | 2010 | 70 | 0.090 |
Why?
|
Arthroplasty, Replacement | 1 | 2010 | 37 | 0.090 |
Why?
|
Brain | 1 | 2020 | 2211 | 0.090 |
Why?
|
Activities of Daily Living | 3 | 1998 | 202 | 0.090 |
Why?
|
Carcinogenicity Tests | 1 | 2009 | 5 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2011 | 108 | 0.090 |
Why?
|
Syndrome | 3 | 2003 | 446 | 0.090 |
Why?
|
Prognosis | 5 | 2015 | 3669 | 0.090 |
Why?
|
Electrodiagnosis | 1 | 2009 | 7 | 0.090 |
Why?
|
Osteoarthritis | 1 | 2010 | 73 | 0.090 |
Why?
|
Femoral Fractures | 1 | 2009 | 32 | 0.090 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2009 | 16 | 0.090 |
Why?
|
Poisoning | 2 | 1986 | 42 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2015 | 2699 | 0.090 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2009 | 57 | 0.090 |
Why?
|
Rats, Inbred F344 | 5 | 2007 | 156 | 0.090 |
Why?
|
Stroke Volume | 1 | 2011 | 452 | 0.090 |
Why?
|
Bone Cysts | 1 | 1988 | 10 | 0.090 |
Why?
|
Poverty | 1 | 2010 | 171 | 0.090 |
Why?
|
Scapula | 1 | 1988 | 23 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2015 | 1671 | 0.080 |
Why?
|
Liver Cirrhosis, Biliary | 3 | 1982 | 29 | 0.080 |
Why?
|
Case-Control Studies | 4 | 2015 | 1801 | 0.080 |
Why?
|
Menisci, Tibial | 2 | 2013 | 25 | 0.080 |
Why?
|
Obesity | 1 | 2014 | 962 | 0.080 |
Why?
|
Carcinoma | 1 | 2011 | 434 | 0.080 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2007 | 86 | 0.080 |
Why?
|
Joints | 1 | 2007 | 32 | 0.080 |
Why?
|
Occult Blood | 1 | 2006 | 16 | 0.070 |
Why?
|
Interleukin-1beta | 1 | 2007 | 78 | 0.070 |
Why?
|
Chemoprevention | 2 | 2018 | 91 | 0.070 |
Why?
|
Age Factors | 5 | 2012 | 1842 | 0.070 |
Why?
|
Critical Care | 1 | 2009 | 368 | 0.070 |
Why?
|
Azoxymethane | 4 | 2007 | 82 | 0.070 |
Why?
|
Costs and Cost Analysis | 1 | 2006 | 153 | 0.070 |
Why?
|
Dupuytren Contracture | 2 | 1996 | 2 | 0.070 |
Why?
|
Veterans | 1 | 2006 | 71 | 0.070 |
Why?
|
Blood Pressure | 1 | 2011 | 1143 | 0.070 |
Why?
|
Ectromelia | 1 | 1985 | 4 | 0.070 |
Why?
|
Myositis Ossificans | 1 | 1985 | 3 | 0.070 |
Why?
|
Endoscopy, Digestive System | 1 | 2006 | 65 | 0.070 |
Why?
|
Artificial Limbs | 1 | 1985 | 20 | 0.070 |
Why?
|
Equipment Design | 3 | 2015 | 405 | 0.070 |
Why?
|
Blood Glucose | 1 | 2009 | 873 | 0.070 |
Why?
|
Down-Regulation | 1 | 2007 | 504 | 0.070 |
Why?
|
Algorithms | 2 | 2004 | 1828 | 0.070 |
Why?
|
Atlanto-Axial Joint | 1 | 1984 | 8 | 0.060 |
Why?
|
Constriction, Pathologic | 2 | 2016 | 212 | 0.060 |
Why?
|
Homeostasis | 1 | 2007 | 408 | 0.060 |
Why?
|
beta Catenin | 1 | 2006 | 250 | 0.060 |
Why?
|
Joint Dislocations | 1 | 1984 | 27 | 0.060 |
Why?
|
Gastric Bypass | 1 | 2006 | 110 | 0.060 |
Why?
|
Pilot Projects | 4 | 2009 | 837 | 0.060 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2004 | 62 | 0.060 |
Why?
|
Postoperative Complications | 4 | 2020 | 2183 | 0.060 |
Why?
|
Hand | 2 | 2003 | 130 | 0.060 |
Why?
|
Endosonography | 1 | 2004 | 96 | 0.060 |
Why?
|
Intellectual Disability | 2 | 2003 | 185 | 0.060 |
Why?
|
Fibroma | 2 | 1995 | 32 | 0.060 |
Why?
|
Australia | 1 | 2023 | 99 | 0.060 |
Why?
|
Contrast Media | 1 | 2008 | 1076 | 0.060 |
Why?
|
Microcirculation | 3 | 2009 | 103 | 0.060 |
Why?
|
Cutis Laxa | 1 | 2003 | 4 | 0.060 |
Why?
|
Hair Diseases | 1 | 2003 | 9 | 0.060 |
Why?
|
Sampling Studies | 1 | 2003 | 70 | 0.060 |
Why?
|
Gonadal Dysgenesis | 1 | 2002 | 3 | 0.060 |
Why?
|
Immune Complex Diseases | 1 | 1982 | 19 | 0.060 |
Why?
|
Facial Expression | 1 | 2003 | 51 | 0.050 |
Why?
|
Endocrine System Diseases | 1 | 2002 | 23 | 0.050 |
Why?
|
Microscopy | 2 | 2013 | 87 | 0.050 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2013 | 201 | 0.050 |
Why?
|
Double-Blind Method | 2 | 2018 | 1822 | 0.050 |
Why?
|
Bone Diseases, Metabolic | 1 | 2002 | 32 | 0.050 |
Why?
|
Antigen-Antibody Complex | 1 | 1982 | 87 | 0.050 |
Why?
|
Animals | 9 | 2018 | 26518 | 0.050 |
Why?
|
Electric Stimulation Therapy | 2 | 2013 | 50 | 0.050 |
Why?
|
Patient Satisfaction | 2 | 1998 | 452 | 0.050 |
Why?
|
Terminology as Topic | 2 | 2001 | 217 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 1610 | 0.050 |
Why?
|
Computers | 1 | 2021 | 109 | 0.050 |
Why?
|
Immobilization | 2 | 2012 | 22 | 0.050 |
Why?
|
Diarrhea | 1 | 2022 | 181 | 0.050 |
Why?
|
Developmental Disabilities | 1 | 2003 | 194 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2014 | 2227 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 1995 | 645 | 0.050 |
Why?
|
Splints | 2 | 2011 | 10 | 0.050 |
Why?
|
Reoperation | 1 | 2023 | 589 | 0.050 |
Why?
|
Casts, Surgical | 2 | 2011 | 10 | 0.050 |
Why?
|
Tibial Meniscus Injuries | 1 | 2001 | 19 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2021 | 8431 | 0.050 |
Why?
|
Absorbable Implants | 1 | 2001 | 34 | 0.050 |
Why?
|
Rupture | 2 | 2010 | 62 | 0.050 |
Why?
|
Foreign-Body Migration | 1 | 2001 | 35 | 0.050 |
Why?
|
Weight-Bearing | 2 | 2010 | 61 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2015 | 751 | 0.050 |
Why?
|
Knee Injuries | 1 | 2001 | 53 | 0.050 |
Why?
|
Bone Transplantation | 2 | 2011 | 64 | 0.050 |
Why?
|
Neonatal Screening | 1 | 2001 | 59 | 0.050 |
Why?
|
Neuromuscular Blockade | 1 | 2000 | 26 | 0.050 |
Why?
|
Morbidity | 1 | 2020 | 146 | 0.050 |
Why?
|
Optics and Photonics | 2 | 2013 | 27 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2015 | 1932 | 0.050 |
Why?
|
Risk Assessment | 3 | 2015 | 2253 | 0.040 |
Why?
|
Pregnancy | 2 | 2018 | 2885 | 0.040 |
Why?
|
Phthalic Acids | 1 | 2018 | 4 | 0.040 |
Why?
|
Polyethylene | 1 | 2018 | 8 | 0.040 |
Why?
|
Laparoscopy | 1 | 2006 | 746 | 0.040 |
Why?
|
Transcription Factors | 1 | 2006 | 1555 | 0.040 |
Why?
|
Self-Assessment | 1 | 1998 | 47 | 0.040 |
Why?
|
Inflammation | 2 | 2018 | 913 | 0.040 |
Why?
|
Enzyme Replacement Therapy | 1 | 2018 | 2 | 0.040 |
Why?
|
Placebo Effect | 1 | 2018 | 31 | 0.040 |
Why?
|
Random Allocation | 1 | 2018 | 332 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2018 | 296 | 0.040 |
Why?
|
Immunomodulation | 1 | 2018 | 55 | 0.040 |
Why?
|
Craniofacial Dysostosis | 1 | 1977 | 12 | 0.040 |
Why?
|
Suture Techniques | 1 | 2018 | 134 | 0.040 |
Why?
|
Sex Factors | 2 | 2012 | 1053 | 0.040 |
Why?
|
Calcaneus | 1 | 1977 | 34 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2018 | 205 | 0.040 |
Why?
|
Incidence | 3 | 2013 | 1568 | 0.040 |
Why?
|
Fantasy | 1 | 2016 | 3 | 0.040 |
Why?
|
Interviews as Topic | 1 | 2018 | 319 | 0.040 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 1996 | 16 | 0.040 |
Why?
|
Databases, Factual | 1 | 2020 | 808 | 0.040 |
Why?
|
Pregnancy Outcome | 1 | 2018 | 247 | 0.040 |
Why?
|
Charcoal | 2 | 1986 | 13 | 0.040 |
Why?
|
Cohort Studies | 2 | 2006 | 2759 | 0.040 |
Why?
|
Hand Deformities, Congenital | 1 | 1976 | 15 | 0.040 |
Why?
|
Obstetrics | 1 | 2018 | 120 | 0.040 |
Why?
|
Hemoglobins | 2 | 2008 | 179 | 0.040 |
Why?
|
Radius | 1 | 1976 | 29 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2000 | 850 | 0.040 |
Why?
|
Fibroblast Growth Factors | 1 | 1996 | 80 | 0.030 |
Why?
|
Point Mutation | 1 | 1996 | 246 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2018 | 1014 | 0.030 |
Why?
|
Dinoprostone | 1 | 2015 | 69 | 0.030 |
Why?
|
Bone Diseases | 1 | 2016 | 54 | 0.030 |
Why?
|
Duodenoscopes | 1 | 2015 | 7 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 1996 | 248 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2018 | 337 | 0.030 |
Why?
|
Polysomnography | 1 | 2015 | 150 | 0.030 |
Why?
|
Multimodal Imaging | 1 | 2015 | 110 | 0.030 |
Why?
|
Home Nursing | 1 | 1994 | 19 | 0.030 |
Why?
|
Back Pain | 1 | 1994 | 42 | 0.030 |
Why?
|
Respiratory Tract Diseases | 1 | 1994 | 45 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2006 | 3087 | 0.030 |
Why?
|
Glucuronosyltransferase | 1 | 2015 | 184 | 0.030 |
Why?
|
Fetal Diseases | 1 | 1994 | 81 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 133 | 0.030 |
Why?
|
Flatfoot | 1 | 1993 | 7 | 0.030 |
Why?
|
Gene Expression | 2 | 1996 | 1281 | 0.030 |
Why?
|
Acupuncture Therapy | 1 | 2013 | 11 | 0.030 |
Why?
|
Cost of Illness | 1 | 1994 | 150 | 0.030 |
Why?
|
Cementation | 1 | 1993 | 4 | 0.030 |
Why?
|
Osteotomy | 1 | 2013 | 31 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2013 | 42 | 0.030 |
Why?
|
Massachusetts | 1 | 1993 | 33 | 0.030 |
Why?
|
Index of Orthodontic Treatment Need | 1 | 2013 | 1 | 0.030 |
Why?
|
Oral Hygiene | 1 | 2013 | 3 | 0.030 |
Why?
|
Evidence-Based Dentistry | 1 | 2013 | 10 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1993 | 71 | 0.030 |
Why?
|
Spinal Diseases | 1 | 1993 | 44 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2013 | 78 | 0.030 |
Why?
|
Hip Prosthesis | 1 | 1993 | 34 | 0.030 |
Why?
|
Counseling | 1 | 1994 | 144 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2013 | 185 | 0.030 |
Why?
|
Nanotechnology | 1 | 2013 | 68 | 0.030 |
Why?
|
Ligaments, Articular | 2 | 2011 | 35 | 0.030 |
Why?
|
Walking | 1 | 1993 | 86 | 0.030 |
Why?
|
Fibroblasts | 3 | 2007 | 729 | 0.030 |
Why?
|
Soft Tissue Neoplasms | 2 | 1992 | 126 | 0.030 |
Why?
|
Hydroxycholecalciferols | 2 | 1982 | 13 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2013 | 69 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2013 | 88 | 0.030 |
Why?
|
Bacteremia | 1 | 2013 | 99 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 263 | 0.030 |
Why?
|
Weight Loss | 1 | 2013 | 229 | 0.030 |
Why?
|
Phenotype | 1 | 2018 | 2375 | 0.030 |
Why?
|
Ganglionectomy | 1 | 1991 | 2 | 0.030 |
Why?
|
Arteriovenous Malformations | 1 | 1992 | 41 | 0.030 |
Why?
|
Hip Dislocation | 1 | 1991 | 10 | 0.030 |
Why?
|
Fracture Healing | 1 | 2011 | 34 | 0.030 |
Why?
|
Optical Phenomena | 1 | 2011 | 7 | 0.030 |
Why?
|
Bone Wires | 1 | 2011 | 12 | 0.030 |
Why?
|
Colonoscopes | 1 | 2011 | 11 | 0.030 |
Why?
|
Orthotic Devices | 1 | 2011 | 9 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2007 | 1752 | 0.030 |
Why?
|
Ganglia, Spinal | 1 | 1991 | 72 | 0.030 |
Why?
|
Calcitonin | 1 | 2011 | 38 | 0.030 |
Why?
|
Vertebroplasty | 1 | 2011 | 8 | 0.020 |
Why?
|
Nanostructures | 1 | 2012 | 77 | 0.020 |
Why?
|
Chromatin | 1 | 2014 | 378 | 0.020 |
Why?
|
Fluorescence | 1 | 2011 | 102 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 1992 | 165 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2007 | 2810 | 0.020 |
Why?
|
Diphosphonates | 1 | 2011 | 36 | 0.020 |
Why?
|
Thiophenes | 1 | 2011 | 48 | 0.020 |
Why?
|
Disease Progression | 2 | 2006 | 1531 | 0.020 |
Why?
|
Genotype | 1 | 2015 | 1850 | 0.020 |
Why?
|
Bone Density Conservation Agents | 1 | 2011 | 45 | 0.020 |
Why?
|
Nerve Block | 1 | 2011 | 51 | 0.020 |
Why?
|
Decompression, Surgical | 1 | 2011 | 87 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2011 | 3347 | 0.020 |
Why?
|
Contraindications | 1 | 2010 | 71 | 0.020 |
Why?
|
Video Recording | 1 | 2011 | 190 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2011 | 132 | 0.020 |
Why?
|
Diaphyses | 1 | 2009 | 6 | 0.020 |
Why?
|
Gastric Lavage | 2 | 1986 | 3 | 0.020 |
Why?
|
Phlebotomy | 1 | 2009 | 21 | 0.020 |
Why?
|
Arm | 2 | 1992 | 91 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2010 | 83 | 0.020 |
Why?
|
In Situ Hybridization | 3 | 1995 | 307 | 0.020 |
Why?
|
Duodenal Neoplasms | 1 | 2009 | 19 | 0.020 |
Why?
|
Time Factors | 2 | 2009 | 5198 | 0.020 |
Why?
|
Rotator Cuff Injuries | 1 | 2010 | 46 | 0.020 |
Why?
|
Pain Measurement | 1 | 2011 | 321 | 0.020 |
Why?
|
Thromboembolism | 1 | 2010 | 119 | 0.020 |
Why?
|
Automation | 1 | 2009 | 106 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2009 | 96 | 0.020 |
Why?
|
Catheterization, Peripheral | 1 | 2009 | 58 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2010 | 277 | 0.020 |
Why?
|
Postoperative Care | 1 | 2010 | 220 | 0.020 |
Why?
|
Polyps | 1 | 2009 | 28 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2013 | 411 | 0.020 |
Why?
|
Curettage | 1 | 1988 | 12 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 2009 | 110 | 0.020 |
Why?
|
Computer Simulation | 1 | 2013 | 1077 | 0.020 |
Why?
|
Biomarkers | 1 | 2015 | 1709 | 0.020 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2008 | 8 | 0.020 |
Why?
|
Gene Silencing | 1 | 2009 | 172 | 0.020 |
Why?
|
ROC Curve | 1 | 2011 | 752 | 0.020 |
Why?
|
Area Under Curve | 1 | 2009 | 334 | 0.020 |
Why?
|
Particle Size | 1 | 2008 | 121 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2011 | 997 | 0.020 |
Why?
|
Administration, Oral | 2 | 1986 | 683 | 0.020 |
Why?
|
Hemangioma | 2 | 1992 | 59 | 0.020 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2007 | 45 | 0.020 |
Why?
|
Mice | 3 | 2006 | 11313 | 0.020 |
Why?
|
Carcinogens | 1 | 2007 | 108 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 1680 | 0.020 |
Why?
|
Reference Values | 1 | 2008 | 673 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2009 | 912 | 0.020 |
Why?
|
Anticoagulants | 1 | 2010 | 404 | 0.020 |
Why?
|
Hemoperfusion | 1 | 1986 | 5 | 0.020 |
Why?
|
Snail Family Transcription Factors | 1 | 2006 | 26 | 0.020 |
Why?
|
Thiamine | 1 | 1986 | 8 | 0.020 |
Why?
|
Methods | 1 | 1986 | 152 | 0.020 |
Why?
|
Antidotes | 1 | 1986 | 23 | 0.020 |
Why?
|
Cathartics | 1 | 1986 | 27 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2006 | 83 | 0.020 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2006 | 26 | 0.020 |
Why?
|
Digestive System Neoplasms | 1 | 2006 | 20 | 0.020 |
Why?
|
Medical History Taking | 1 | 1986 | 80 | 0.020 |
Why?
|
Urine | 1 | 1986 | 90 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2008 | 426 | 0.020 |
Why?
|
Fascia | 2 | 1996 | 29 | 0.020 |
Why?
|
Arthritis, Infectious | 1 | 1985 | 16 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2006 | 229 | 0.020 |
Why?
|
Cadherins | 1 | 2006 | 151 | 0.020 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2005 | 40 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2007 | 163 | 0.020 |
Why?
|
Celecoxib | 1 | 2005 | 31 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1986 | 493 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 1985 | 220 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-sis | 2 | 1995 | 27 | 0.020 |
Why?
|
RNA, Messenger | 3 | 1996 | 1975 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2006 | 1040 | 0.020 |
Why?
|
Acute Disease | 1 | 1986 | 824 | 0.020 |
Why?
|
Blotting, Northern | 2 | 1996 | 256 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 1985 | 160 | 0.020 |
Why?
|
MicroRNAs | 1 | 2009 | 534 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2007 | 632 | 0.020 |
Why?
|
Fractals | 1 | 2004 | 42 | 0.020 |
Why?
|
Pyrazoles | 1 | 2005 | 153 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2006 | 3616 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2007 | 1917 | 0.020 |
Why?
|
Electrocardiography | 1 | 1986 | 478 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2004 | 131 | 0.010 |
Why?
|
Preoperative Care | 1 | 2006 | 390 | 0.010 |
Why?
|
Quality of Life | 1 | 1991 | 1575 | 0.010 |
Why?
|
Glucose | 1 | 1986 | 637 | 0.010 |
Why?
|
Sulfonamides | 1 | 2005 | 299 | 0.010 |
Why?
|
Obesity, Morbid | 1 | 2006 | 219 | 0.010 |
Why?
|
Renal Dialysis | 1 | 1986 | 354 | 0.010 |
Why?
|
Complement Activating Enzymes | 1 | 1982 | 3 | 0.010 |
Why?
|
Complement C1q | 1 | 1982 | 10 | 0.010 |
Why?
|
Rheumatoid Factor | 1 | 1982 | 24 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1982 | 155 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 1995 | 927 | 0.010 |
Why?
|
Body Mass Index | 1 | 2006 | 770 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2006 | 662 | 0.010 |
Why?
|
Osteoma, Osteoid | 1 | 1981 | 9 | 0.010 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1982 | 106 | 0.010 |
Why?
|
Tibial Fractures | 1 | 1981 | 39 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2006 | 1571 | 0.010 |
Why?
|
Device Removal | 1 | 2001 | 159 | 0.010 |
Why?
|
Vitamin D | 1 | 1981 | 261 | 0.010 |
Why?
|
Torticollis | 1 | 1978 | 11 | 0.010 |
Why?
|
Pain | 1 | 1981 | 389 | 0.010 |
Why?
|
Congenital Abnormalities | 1 | 1977 | 63 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1982 | 541 | 0.010 |
Why?
|
Procollagen | 1 | 1996 | 8 | 0.010 |
Why?
|
Gastroesophageal Reflux | 1 | 1978 | 117 | 0.010 |
Why?
|
Bromodeoxyuridine | 1 | 1996 | 57 | 0.010 |
Why?
|
Neutralization Tests | 1 | 1996 | 77 | 0.010 |
Why?
|
Orofaciodigital Syndromes | 1 | 1976 | 2 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1996 | 129 | 0.010 |
Why?
|
Thumb | 1 | 1976 | 22 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1976 | 114 | 0.010 |
Why?
|
Hematologic Diseases | 1 | 1976 | 79 | 0.010 |
Why?
|
Signal Transduction | 1 | 2006 | 3233 | 0.010 |
Why?
|
Muscles | 1 | 1976 | 192 | 0.010 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1995 | 49 | 0.010 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 1995 | 19 | 0.010 |
Why?
|
Fibromatosis, Aggressive | 1 | 1995 | 10 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1995 | 129 | 0.010 |
Why?
|
Cell Division | 1 | 1996 | 696 | 0.010 |
Why?
|
Orthopedic Fixation Devices | 1 | 1994 | 5 | 0.010 |
Why?
|
Progesterone | 1 | 1995 | 107 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 1976 | 386 | 0.010 |
Why?
|
Estrogens | 1 | 1995 | 197 | 0.010 |
Why?
|
Intestinal Absorption | 2 | 1986 | 123 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 1976 | 350 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 1993 | 111 | 0.010 |
Why?
|
Calcifediol | 2 | 1982 | 21 | 0.010 |
Why?
|
Oncogenes | 1 | 1992 | 88 | 0.010 |
Why?
|
Ultrasonography | 1 | 1994 | 695 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1992 | 314 | 0.010 |
Why?
|
Lymphocytes | 1 | 1993 | 461 | 0.010 |
Why?
|
Base Sequence | 1 | 1995 | 2329 | 0.010 |
Why?
|
Bone and Bones | 2 | 1982 | 264 | 0.010 |
Why?
|
Prevalence | 1 | 1994 | 1239 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 1992 | 382 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 3029 | 0.010 |
Why?
|
Macrophages | 1 | 1993 | 554 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1992 | 1196 | 0.000 |
Why?
|
Metabolic Clearance Rate | 1 | 1986 | 121 | 0.000 |
Why?
|
Kinetics | 1 | 1986 | 1513 | 0.000 |
Why?
|
Hand Deformities, Acquired | 1 | 1982 | 5 | 0.000 |
Why?
|
Anemia, Hypochromic | 1 | 1982 | 5 | 0.000 |
Why?
|
24,25-Dihydroxyvitamin D 3 | 1 | 1981 | 2 | 0.000 |
Why?
|
Dihydroxycholecalciferols | 1 | 1981 | 10 | 0.000 |
Why?
|
Cervical Atlas | 1 | 1978 | 4 | 0.000 |
Why?
|